Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 661 AL 675

Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation

Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI.

Brain Res. 2012 Mar 2;1441:64-78. doi: 10.1016/j.brainres.2011.12.063. Epub 2012 Jan 12.

Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis

Guan F, Gu J, Hu F, Zhu Y, Wang W.

Mol Biol Rep. 2012 Jun;39(6):6661-9. doi: 10.1007/s11033-012-1472-8.

Semantic memory and language dysfunction in early Alzheimer's disease: a review

Verma M, Howard RJ.

Int J Geriatr Psychiatry. 2012 Dec;27(12):1209-17. doi: 10.1002/gps.3766. Epub 2012 Feb 1.

Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model

Maloney B, Sambamurti K, Zawia N, Lahiri DK.

Curr Alzheimer Res. 2012 Jun;9(5):589-99. doi: 10.2174/156720512800617955.

Citalopram for agitation in Alzheimer's disease: design and methods

Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG; CitAD Research Group.

Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.

The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout

Chang KA, Kim HJ, Suh YH.

Neurodegener Dis. 2012;10(1-4):27-9. doi: 10.1159/000333781. Epub 2012 Feb 1.

Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease

Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing Research Group.

Neurodegener Dis. 2012;10(1-4):141-4. doi: 10.1159/000334295. Epub 2012 Feb 1.

Memory loss

Flicker LA, Ford AH, Beer CD, Almeida OP.

Med J Aust. 2012 Feb 6;196:114-7. doi: 10.5694/mja11.11399.

Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort

Gonfrier S, Andrieu S, Renaud D, Vellas B, Robert PH.

J Nutr Health Aging. 2012 Feb;16(2):134-7. doi: 10.1007/s12603-011-0147-9.

Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis

Bellassen V, Iglói K, de Souza LC, Dubois B, Rondi-Reig L.

J Neurosci. 2012 Feb 8;32(6):1942-52. doi: 10.1523/JNEUROSCI.4556-11.2012.

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment

Di Maria E, Giorgio E, Uliana V, Bonvicini C, Faravelli F, Cammarata S, Novello MC, Galimberti D, Scarpini E, Zanetti O, Gennarelli M, Tabaton M.

J Alzheimers Dis. 2012;29(3):699-705. doi: 10.3233/JAD-2012-112006.

New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements

Clerx L, Visser PJ, Verhey F, Aalten P.

J Alzheimers Dis. 2012;29(2):405-29. doi: 10.3233/JAD-2011-110797.

Platelet activation in Alzheimer's disease: from pathophysiology to clinical value

Laske C, Sopova K, Stellos K.

Curr Vasc Pharmacol. 2012 Sep;10(5):626-30. doi: 10.2174/157016112801784657.

Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares

Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Caselli RJ, Reiman EM.

Neuroimage. 2012 May 1;60(4):2316-22. doi: 10.1016/j.neuroimage.2012.02.005. Epub 2012 Feb 12.

Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia

Suzuki Y, Saito M, Someya T.

Psychiatry Clin Neurosci. 2012 Mar;66(2):166. doi: 10.1111/j.1440-1819.2011.02316.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias